Literature DB >> 23571270

CB₁ cannabinoid receptors promote maximal FAK catalytic activity by stimulating cooperative signaling between receptor tyrosine kinases and integrins in neuronal cells.

George D Dalton1, Lynda J Peterson, Allyn C Howlett.   

Abstract

Tyrosine phosphorylation (Tyr-P) of focal adhesion kinase (FAK) regulates FAK activation. Phosphorylated FAK Tyr 397 binds Src family kinases (Src), which in turn directly phosphorylate FAK Tyr 576/577 to produce maximal FAK enzymatic activity. CB₁ cannabinoid receptors (CB₁) are abundantly expressed in the nervous system and influence FAK activation by presently unknown mechanisms. The current investigation determined that CB₁-stimulated maximal FAK catalytic activity is mediated by Gi/o proteins in N18TG2 neuronal cells, and that G12/13 regulation of Rac1 and RhoA occurs concomitantly. Immunoblotting analyses using antibodies against FAK phospho-Tyr 397 and phospho-Tyr 576/577 demonstrated that the time-course of CB₁-stimulated FAK 576/577 Tyr-P occurred in three phases: Phase I (0-2 min) maximal Tyr-P, Phase II (5-20 min) rapid decline in Tyr-P, and Phase III (>20 min) plateau in Tyr-P at submaximal levels. In contrast, FAK 397 Tyr-P was monophasic and significantly lower in magnitude. FAK 397 Tyr-P and Phase I FAK 576/577 Tyr-P involved protein tyrosine phosphatase (PTP1B and Shp1/Shp2)-mediated Src activation, Protein Kinase A (PKA) inhibition, and integrin activation. Phase I maximal FAK 576/577 Tyr-P also required cooperative signaling between receptor tyrosine kinases (RTKs) and integrins. The integrin antagonist RGDS peptide, Flk-1 vascular endothelial growth factor receptor (VEGFR) antagonist SU5416, and epidermal growth factor receptor (EGFR) antagonist AG 1478 blocked Phase I FAK 576/577 Tyr-P. CB₁ agonists failed to stimulate FAK Tyr-P in the absence of integrin activation upon suspension in serum-free culture media. In contrast, cells grown on the integrin ligands fibronectin and laminin displayed increased FAK 576/577 Tyr-P that was augmented by CB₁ agonists and blocked by the Src inhibitor PP2 and Flk-1 VEGFR antagonist SU5416. Taken together, these studies have identified a complex integrative pathway utilized by CB₁ to stimulate maximal FAK 576/577 Tyr-P in neuronal cells.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23571270      PMCID: PMC4165595          DOI: 10.1016/j.cellsig.2013.03.020

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  62 in total

Review 1.  Control of the cell survival/death decision by cannabinoids.

Authors:  M Guzmán; C Sánchez; I Galve-Roperh
Journal:  J Mol Med (Berl)       Date:  2001       Impact factor: 4.599

2.  Discovery of a novel shp2 protein tyrosine phosphatase inhibitor.

Authors:  Liwei Chen; Shen-Shu Sung; M L Richard Yip; Harshani R Lawrence; Yuan Ren; Wayne C Guida; Said M Sebti; Nicholas J Lawrence; Jie Wu
Journal:  Mol Pharmacol       Date:  2006-05-22       Impact factor: 4.436

Review 3.  PTP1B and TC-PTP: regulators of transformation and tumorigenesis.

Authors:  Matthew Stuible; Karen M Doody; Michel L Tremblay
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

4.  Src kinase activity is regulated by the SHP-1 protein-tyrosine phosphatase.

Authors:  A K Somani; J S Bignon; G B Mills; K A Siminovitch; D R Branch
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

5.  Activation of RhoA by lysophosphatidic acid and Galpha12/13 subunits in neuronal cells: induction of neurite retraction.

Authors:  O Kranenburg; M Poland; F P van Horck; D Drechsel; A Hall; W H Moolenaar
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

6.  Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation.

Authors:  H Matsuno; J M Stassen; J Vermylen; H Deckmyn
Journal:  Circulation       Date:  1994-11       Impact factor: 29.690

7.  A mechanistic and kinetic analysis of the interactions of the diastereoisomers of adenosine 3',5'-(cyclic)phosphorothioate with purified cyclic AMP-dependent protein kinase.

Authors:  J D Rothermel; L H Parker Botelho
Journal:  Biochem J       Date:  1988-05-01       Impact factor: 3.857

8.  Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase.

Authors:  L Kornberg; H S Earp; J T Parsons; M Schaller; R L Juliano
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

9.  Integrin α5β1 simultaneously controls EGFR-dependent proliferation and Akt-dependent pro-survival signaling in epidermoid carcinoma cells.

Authors:  Galina E Morozevich; Nadezda I Kozlova; Natalia A Ushakova; Marina E Preobrazhenskaya; Albert E Berman
Journal:  Aging (Albany NY)       Date:  2012-05       Impact factor: 5.682

10.  Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor.

Authors:  T Vang; K M Torgersen; V Sundvold; M Saxena; F O Levy; B S Skålhegg; V Hansson; T Mustelin; K Taskén
Journal:  J Exp Med       Date:  2001-02-19       Impact factor: 14.307

View more
  14 in total

1.  Chronic baclofen desensitizes GABA(B)-mediated G-protein activation and stimulates phosphorylation of kinases in mesocorticolimbic rat brain.

Authors:  Bradley M T Keegan; Thomas J R Beveridge; Jeffrey J Pezor; Ruoyu Xiao; Tammy Sexton; Steven R Childers; Allyn C Howlett
Journal:  Neuropharmacology       Date:  2015-02-25       Impact factor: 5.250

2.  Mouse Neuroblastoma CB1 Cannabinoid Receptor-Stimulated [35S]GTPɣS Binding: Total and Antibody-Targeted Gα Protein-Specific Scintillation Proximity Assays.

Authors:  Khalil Eldeeb; Sandra Leone-Kabler; Allyn C Howlett
Journal:  Methods Enzymol       Date:  2017-07-19       Impact factor: 1.600

3.  In silico interaction analysis of cannabinoid receptor interacting protein 1b (CRIP1b) - CB1 cannabinoid receptor.

Authors:  Pratishtha Singh; Anjali Ganjiwale; Allyn C Howlett; Sudha M Cowsik
Journal:  J Mol Graph Model       Date:  2017-09-06       Impact factor: 2.518

Review 4.  CB1 and CB2 Receptor Pharmacology.

Authors:  Allyn C Howlett; Mary E Abood
Journal:  Adv Pharmacol       Date:  2017-06-12

5.  Atypical Endocannabinoid Signaling Initiates a New Form of Memory-Related Plasticity at a Cortical Input to Hippocampus.

Authors:  Weisheng Wang; Yousheng Jia; Danielle T Pham; Linda C Palmer; Kwang-Mook Jung; Conor D Cox; Gavin Rumbaugh; Daniele Piomelli; Christine M Gall; Gary Lynch
Journal:  Cereb Cortex       Date:  2018-07-01       Impact factor: 5.357

6.  Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice.

Authors:  Aníbal Sánchez-de la Torre; Tania Aguado; Alba Huerga-Gómez; Silvia Santamaría; Antonietta Gentile; Juan Carlos Chara; Carlos Matute; Krisztina Monory; Susana Mato; Manuel Guzmán; Beat Lutz; Ismael Galve-Roperh; Javier Palazuelos
Journal:  Cell Death Dis       Date:  2022-07-07       Impact factor: 9.685

7.  CB1 cannabinoid receptors couple to focal adhesion kinase to control insulin release.

Authors:  Katarzyna Malenczyk; Magdalena Jazurek; Erik Keimpema; Cristoforo Silvestri; Justyna Janikiewicz; Ken Mackie; Vincenzo Di Marzo; Maria J Redowicz; Tibor Harkany; Agnieszka Dobrzyn
Journal:  J Biol Chem       Date:  2013-10-02       Impact factor: 5.157

8.  Elucidation of the roles of the Src kinases in pancreatic acinar cell signaling.

Authors:  Bernardo Nuche-Berenguer; Paola Moreno; R T Jensen
Journal:  J Cell Biochem       Date:  2015-01       Impact factor: 4.429

9.  A Primary Cortical Input to Hippocampus Expresses a Pathway-Specific and Endocannabinoid-Dependent Form of Long-Term Potentiation.

Authors:  Weisheng Wang; Brian H Trieu; Linda C Palmer; Yousheng Jia; Danielle T Pham; Kwang-Mook Jung; Carley A Karsten; Collin B Merrill; Ken Mackie; Christine M Gall; Daniele Piomelli; Gary Lynch
Journal:  eNeuro       Date:  2016-08-08

10.  Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex.

Authors:  Rebeca Diez-Alarcia; Inés Ibarra-Lecue; Ángela P Lopez-Cardona; Javier Meana; Alfonso Gutierrez-Adán; Luis F Callado; Ekaitz Agirregoitia; Leyre Urigüen
Journal:  Front Pharmacol       Date:  2016-11-04       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.